Cargando…
The mode of action of the Protein tyrosine phosphatase 1B inhibitor Ertiprotafib
Protein tyrosine phosphatase 1B (PTP1B) is a validated therapeutic target for the treatment of diabetes and obesity. Ertiprotafib is a PTP1B inhibitor that reached the clinical trial stage for the treatment of diabetes. Interestingly, Ertiprotafib reduces the melting temperature of PTP1B in differen...
Autores principales: | Kumar, Ganesan Senthil, Page, Rebecca, Peti, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531832/ https://www.ncbi.nlm.nih.gov/pubmed/33007022 http://dx.doi.org/10.1371/journal.pone.0240044 |
Ejemplares similares
-
Structural insights into mode of actions of novel natural Mycobacterium protein tyrosine phosphatase B inhibitors
por: Dhanjal, Jaspreet Kaur, et al.
Publicado: (2014) -
The ribosomal RNA processing 1B:protein phosphatase 1 holoenzyme reveals non-canonical PP1 interaction motifs
por: Srivastava, Gautam, et al.
Publicado: (2022) -
Identification of the substrate recruitment mechanism of the muscle glycogen protein phosphatase 1 holoenzyme
por: Kumar, Ganesan Senthil, et al.
Publicado: (2018) -
Interaction of Kinase-Interaction-Motif Protein Tyrosine Phosphatases with the Mitogen-Activated Protein Kinase ERK2
por: Francis, Dana M., et al.
Publicado: (2014) -
The Ki-67 and RepoMan mitotic phosphatases assemble via an identical, yet novel mechanism
por: Kumar, Ganesan Senthil, et al.
Publicado: (2016)